advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (90)
Showing records 1 to 25
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation71633 Six month delivery of gdnf from plga/vitamin e biodegradable microspheres after intravitreal injection in rabbits
García-Caballero C
European Journal of Pharmaceutical Sciences 2017; 103: 19-26
71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Zhao L
Journal of Controlled Release 2017; 247: 153-166
71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Chandrawati R
Advanced materials (Deerfield Beach, Fla.) 2017; 29:
71416 Nimodipine Ophthalmic Formulations for Management of Glaucoma
Maria DN
Pharmaceutical Research 2017; 34: 809-824
71287 Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies
Mandal A
Journal of Controlled Release 2017; 248: 96-116
71499 Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma
Lorenz K
PLoS ONE 2017; 12: e0171636
71548 PLGA Nanoparticles as Subconjunctival Injection for Management of Glaucoma
Salama HA
AAPS PharmSciTech 2017; 18: 2517-2528
71529 Topical medication instillation techniques for glaucoma
Xu L
Cochrane Database of Systematic Reviews 2017; 2: CD010520
71292 Chitosan-g-poly(N-isopropylacrylamide) copolymers as delivery carriers for intracameral pilocarpine administration
Lai JY
European Journal of Pharmaceutics and Biopharmaceutics 2017; 113: 140-148
71551 The physical properties of generic latanoprost ophthalmic solutions are not identical
Kolko M
Acta Ophthalmologica 2017; 95: 370-373
71312 Sustained-Release Delivery System of a Slow Hydrogen Sulfide Donor, GYY 4137, for Potential Application in Glaucoma
Patil A
AAPS PharmSciTech 2017; 18: 2291-2302
71521 Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma
Bouchemi M
Toxicology in Vitro 2017; 41: 21-29
71478 In vivo Pharmacological Evaluations of Pilocarpine-Loaded Antioxidant-Functionalized Biodegradable Thermogels in Glaucomatous Rabbits
Chou SF
Scientific reports 2017; 7: 42344
71498 Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma
Sun J
ACS applied materials & interfaces 2017; 9: 7990-7999
71417 Optimizing novel penetration enhancing hybridized vesicles for augmenting the in-vivo effect of an anti-glaucoma drug
Naguib SS
Drug Delivery 2017; 24: 99-108
71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Park CG
International Journal of Pharmaceutics 2017; 522: 66-73
71292 Chitosan-g-poly(N-isopropylacrylamide) copolymers as delivery carriers for intracameral pilocarpine administration
Luo LJ
European Journal of Pharmaceutics and Biopharmaceutics 2017; 113: 140-148
71521 Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma
Roubeix C
Toxicology in Vitro 2017; 41: 21-29
71542 Localized and Controlled Delivery of Nitric Oxide to the Conventional Outflow Pathway via Enzyme Biocatalysis: Toward Therapy for Glaucoma
Chang JY
Advanced materials (Deerfield Beach, Fla.) 2017; 29:
71240 An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration
Chen G
Journal of Controlled Release 2017; 247: 153-166
71478 In vivo Pharmacological Evaluations of Pilocarpine-Loaded Antioxidant-Functionalized Biodegradable Thermogels in Glaucomatous Rabbits
Luo LJ
Scientific reports 2017; 7: 42344
71498 Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma
Lei Y
ACS applied materials & interfaces 2017; 9: 7990-7999
71416 Nimodipine Ophthalmic Formulations for Management of Glaucoma
Abd-Elgawad AH
Pharmaceutical Research 2017; 34: 809-824
71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Kim YK
International Journal of Pharmaceutics 2017; 522: 66-73
71499 Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma
Wasielica-Poslednik J
PLoS ONE 2017; 12: e0171636
